How to ensure the safety of biosimilars in India
Archana Shanker and Devinder Singh Rawat of Anand & Anand discuss the rise and regulation of biosimilar biologics in the Indian pharmaceutical market
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: